Enantiomers of sulfoxide of albendazole: cerebrospinal fluid and plasma levels and therapeutic efficacy in the treatment of patients with neurocysticercosis
“…In addition, there are no data in the literature over which ALB metabolite (+)-ASOX, (−)-ASOX or both, is actually effective or the respective concentrations required for proper treatment of NCC. In a preliminary study, the (+)-ASOX enantiomer appeared to be the main metabolite against parenchymal brain cysticercosis [65]. Future studies concerning CSF enantiomer concentration and the clinical outcome of NCC would clarify the question over the therapeutic role of each ALB metabolite against the cysticerci.…”
Section: Failure Of Anticysticercal Therapy: Possible Explanationsmentioning
“…In addition, there are no data in the literature over which ALB metabolite (+)-ASOX, (−)-ASOX or both, is actually effective or the respective concentrations required for proper treatment of NCC. In a preliminary study, the (+)-ASOX enantiomer appeared to be the main metabolite against parenchymal brain cysticercosis [65]. Future studies concerning CSF enantiomer concentration and the clinical outcome of NCC would clarify the question over the therapeutic role of each ALB metabolite against the cysticerci.…”
Section: Failure Of Anticysticercal Therapy: Possible Explanationsmentioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.